Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrimaVie for Skin Microperfusion, Hydration, Elasticity, and Barrier Function
NCT02762032Phase 1Completed
- Sponsor
- The Ohio State University
- Start
- Feb 2016
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Phase 1, randomised trial (3 arms), sponsored by The Ohio State University. Primary endpoints: Non-invasive Skin Assessment of Skin Microperfusion at 14 weeks, Non-invasive Skin Assessment of Hydration at 14 weeks and 2 more. Started Feb 2016; status: completed.
Beyond the preview
Go deeper on NCT02762032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02762032.